Balance Sheet

Assets

+5%

+10%

10Y

Currency: JPY

	Mar-2002	Mar-2003	Mar-2004	Mar-2005	Mar-2006	Mar-2007	Mar-2008	Mar-2009	Mar-2010	Mar-2011	Mar-2012	Mar-2013	Mar-2014	Mar-2015	Mar-2016	Mar-2017	Mar-2018	Mar-2019	Mar-2020	Mar-2021	Mar-2022	Mar-2023	Mar-2024	Mar-2025
Assets
Cash & Cash Equivalents	14 439	13 264	13 256	17 271	9 681	10 915	8 288	10 155	9 900	14 729	9 543	9 710	9 644	10 553	29 845	33 867	45 095	46 956	59 722	63 706	61 025	59 561	50 625	54 093
Cash Equivalents	14 439	13 264	13 256	17 271	9 681	10 915	8 288	10 155	9 900	14 729	9 543	9 710	9 644	10 553	29 845	33 867	45 095	46 956	59 722	63 706	61 025	59 561	50 625	54 093
Short-Term Investments	2 191	149	149	149	149	999	4 097	2 401	7 603	2 305	8 308	7 210	7 812	14 214	11 899	9 899	7 599	11 599	13 599	13 599	13 599	14 699	14 699	15 992
Total Receivables	39 426	34 365	32 619	33 549	32 363	34 621	28 037	28 340	27 653	27 117	32 029	31 171	25 361	28 204	29 868	28 231	33 315	30 340	21 800	20 549	20 260	19 268	23 744	21 178
Accounts Receivables	39 426	34 365	32 619	33 549	32 363	34 621	28 037	28 340	27 653	27 117	32 029	31 171	25 361	28 204	29 868	28 231	33 315	30 340	21 800	20 549	20 260	18 986	23 447	20 984
Other Receivables	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	282	297	194
Inventory	9 796	10 206	11 135	10 249	9 657	9 126	9 938	10 945	8 992	10 299	10 924	11 531	13 220	13 482	14 506	16 495	16 651	13 719	12 274	15 197	14 980	15 563	17 167	19 020
Other Current Assets	2 273	2 856	2 998	2 908	3 403	2 937	2 841	3 087	2 672	2 432	2 410	2 361	2 464	2 563	2 873	2 002	1 199	1 117	941	611	749	812	739	1 094
Total Current Assets	68 124	60 840	60 157	64 126	55 253	58 598	53 201	54 928	56 820	56 882	63 214	61 983	58 501	69 016	88 991	90 494	103 859	103 731	108 336	113 662	110 613	109 903	106 974	111 377
PP&E Net	29 052	27 892	26 795	26 401	25 436	25 237	25 150	25 894	25 242	28 148	28 368	29 138	28 516	25 961	26 726	26 271	26 141	26 402	25 518	25 020	25 734	25 498	25 355	27 629
PP&E Gross	29 052	27 892	26 795	26 401	25 436	25 237	25 150	25 894	25 242	28 148	28 368	29 138	28 516	25 961	26 726	26 271	26 141	26 402	25 518	25 020	25 734	25 498	25 355	27 629
Accumulated Depreciation	26 983	28 065	29 660	31 006	30 898	31 822	33 149	34 754	35 617	37 342	38 883	40 634	42 511	42 291	40 348	41 114	41 905	42 482	43 881	44 330	45 564	47 189	48 583	50 208
Intangible Assets	299	318	273	270	297	485	494	448	391	396	966	732	598	474	371	372	552	551	414	625	8 236	6 741	7 462	5 254
Goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14 035
Note Receivable	553	933	1 015	1 081	273	210	149	129	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long-Term Investments	4 642	6 439	6 884	6 842	11 270	10 391	7 733	5 042	5 445	6 079	6 422	10 272	10 994	15 357	14 400	15 943	18 488	17 068	15 036	17 368	17 093	17 511	20 532	18 875
Other Long-Term Assets	11 455	12 087	10 482	9 819	6 200	5 973	7 124	8 055	7 190	6 981	6 138	6 786	7 856	4 327	2 503	1 980	3 377	8 233	8 571	6 657	3 505	6 675	11 300	13 252
Other Assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	14 035
Total Assets	114 125 N/A	108 509 -5%	105 606 -3%	108 539 +3%	98 729 -9%	100 894 +2%	93 851 -7%	94 496 +1%	95 088 +1%	98 486 +4%	105 108 +7%	108 911 +4%	106 465 -2%	115 135 +8%	132 991 +16%	135 060 +2%	152 417 +13%	155 985 +2%	157 875 +1%	163 332 +3%	165 181 +1%	166 328 +1%	171 623 +3%	190 422 +11%
Liabilities
Accounts Payable	14 482	12 711	12 964	12 964	12 301	15 147	13 380	13 172	11 174	12 293	16 331	16 367	13 713	12 295	12 256	11 161	13 452	12 258	8 682	8 569	5 939	6 219	7 099	8 322
Accrued Liabilities	2 600	2 501	2 057	1 879	1 873	2 098	1 994	2 185	2 841	2 095	2 258	2 163	1 725	1 902	2 178	1 792	2 017	1 662	1 710	1 450	1 394	1 561	1 639	2 385
Short-Term Debt	6 204	6 175	5 940	5 380	5 380	5 380	5 380	7 910	8 510	8 390	8 390	8 390	4 195	4 195	3 875	3 875	3 875	3 875	3 850	3 850	3 850	3 850	3 850	3 850
Current Portion of Long-Term Debt	18 984	1 480	607	0	0	1 006	3 000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Current Liabilities	6 354	6 761	3 976	6 794	4 693	7 843	6 523	7 966	6 328	8 683	9 375	8 312	8 423	11 977	15 552	7 192	12 057	9 785	7 413	7 407	7 866	9 208	6 436	15 797
Total Current Liabilities	48 625	29 628	25 544	27 017	24 247	31 474	30 277	31 233	28 853	31 461	36 354	35 232	28 056	30 369	33 861	24 020	31 401	27 580	21 655	21 276	19 049	20 838	19 024	30 354
Long-Term Debt	10 026	21 531	20 849	20 394	13 192	3 000	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Deferred Income Tax	319	290	279	259	239	220	210	200	189	179	150	142	135	0	0	0	0	0	0	0	2 229	1 771	1 947	1 514
Minority Interest	1	1	1	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	578	578	0	0
Other Liabilities	16 136	16 288	15 800	15 381	6 415	5 767	5 914	6 386	6 471	6 470	6 532	6 959	10 178	7 545	9 255	8 385	7 142	7 274	7 752	5 799	5 578	6 883	6 897	5 920
Total Liabilities	75 106 N/A	67 738 -10%	62 473 -8%	63 051 +1%	44 093 -30%	40 461 -8%	36 401 -10%	37 819 +4%	35 513 -6%	38 110 +7%	43 036 +13%	42 333 -2%	38 369 -9%	38 035 -1%	43 116 +13%	32 405 -25%	38 543 +19%	34 854 -10%	29 407 -16%	27 075 -8%	27 434 +1%	30 070 +10%	27 868 -7%	37 788 +36%
Equity
Common Stock	17 000	17 000	17 000	17 127	20 737	23 348	23 853	23 853	23 853	23 853	23 853	23 853	23 853	23 853	23 853	23 853	23 853	23 853	23 853	23 853	23 853	23 853	23 853	23 853
Retained Earnings	6 557	8 406	10 540	12 859	15 428	18 305	21 440	24 698	28 684	33 806	38 672	43 997	49 789	52 932	68 609	84 331	97 284	109 057	114 869	122 462	126 347	126 135	128 506	135 242
Additional Paid In Capital	15 735	15 735	15 735	15 873	19 462	22 226	22 727	11 587	11 587	11 587	11 587	11 587	11 587	11 406	11 407	11 407	11 408	11 408	11 406	11 406	11 406	11 406	11 462	12 932
Unrealized Security Profit/Loss	258	261	987	1 344	2 793	2 322	1 045	43	449	229	550	1 936	2 398	5 478	0	4 611	5 510	4 524	3 116	4 739	4 551	4 724	7 184	6 257
Treasury Stock	16	108	1 130	1 715	3 784	5 771	11 618	3 417	4 999	9 100	12 592	14 796	17 656	16 098	0	19 813	23 259	26 782	23 373	26 304	28 714	30 026	28 613	28 233
Other Equity	0	0	0	0	0	0	0	0	0	0	1	1	1 875	471	2 116	1 734	922	929	1 403	101	304	166	1 363	2 583
Total Equity	39 018 N/A	40 772 +4%	43 132 +6%	45 488 +5%	54 636 +20%	60 430 +11%	57 447 -5%	56 678 -1%	59 574 +5%	60 375 +1%	62 071 +3%	66 578 +7%	68 096 +2%	77 100 +13%	89 875 +17%	102 655 +14%	113 874 +11%	121 131 +6%	128 468 +6%	136 257 +6%	137 747 +1%	136 258 -1%	143 755 +6%	152 634 +6%
Total Liabilities & Equity	114 125 N/A	108 510 -5%	105 605 -3%	108 539 +3%	98 729 -9%	100 891 +2%	93 848 -7%	94 497 +1%	95 087 +1%	98 485 +4%	105 107 +7%	108 911 +4%	106 465 -2%	115 135 +8%	132 991 +16%	135 060 +2%	152 417 +13%	155 985 +2%	157 875 +1%	163 332 +3%	165 181 +1%	166 328 +1%	171 623 +3%	190 422 +11%
Shares Outstanding
Common Shares Outstanding	47	47	46	46	50	53	51	49	48	46	46	43	42	41	41	41	40	40	39	38	38	37	38	38

Income Statement Balance Sheet Cash Flow Statement

Kaken Pharmaceutical Co Ltd
TSE:4521

Balance Sheet

Balance Sheet Decomposition
Kaken Pharmaceutical Co Ltd

Balance Sheet
Kaken Pharmaceutical Co Ltd

See Also

Company

Help

Tools

Stocks

Kaken Pharmaceutical Co Ltd TSE:4521

Balance Sheet

Balance Sheet Decomposition Kaken Pharmaceutical Co Ltd

Balance Sheet Kaken Pharmaceutical Co Ltd

See Also

Company

Help

Tools

Stocks

Kaken Pharmaceutical Co Ltd
TSE:4521

Balance Sheet Decomposition
Kaken Pharmaceutical Co Ltd

Balance Sheet
Kaken Pharmaceutical Co Ltd